CEO
DuVal & Associates, P.A.
Mark DuVal, JD, FRAPS, is the CEO of DuVal & Associates, P.A., a law firm dedicated to counseling companies in the medical device, pharmaceutical, biotech, food, and nutritional supplement industries. His practice includes providing strategic regulatory advice, developing compliance programs, designing and implementing sophisticated marketing programs, counseling on reimbursement matters, conducting sales training, and interfacing with the FDA in relation to product approvals and clearances, clinical trial negotiations, approvals, policy arguments, appeals, etc. He works extensively with FDA on 510(k)s, de novos, PMAs and combination products, IDE negotiations, pre-submissions, inspections, warning letters, appeals, etc.
Preconference Workshop: Survivor: The FDA 510(k) Program Edition (Day 1 of 2)
Monday, October 6, 2025
8:30 AM - 4:00 PM EST
Preconference Workshop: Survivor: The FDA 510(k) Program Edition (Day 2 of 2)
Tuesday, October 7, 2025
8:30 AM - 4:00 PM EST